Article ; Online: Correlation between chest computed tomography findings and pulmonary function test results in the post-recovery phase of COVID-19.
2023 Volume 21, Page(s) eAO0288
Abstract: Objective: The radiological and functional lung sequelae in COVID-19 survivors remain unclear. We compared the chest computed tomography findings of COVID-19 patients with normal and abnormal pulmonary function test results in the post-recovery phase.!## ...
| Abstract | Objective: The radiological and functional lung sequelae in COVID-19 survivors remain unclear. We compared the chest computed tomography findings of COVID-19 patients with normal and abnormal pulmonary function test results in the post-recovery phase. Methods: The data of consecutive patients who underwent pulmonary function tests and chest computed tomography within 14 days after recovery from COVID-19 at two medical centers between May and October 2020 were collected retrospectively. Two thoracic radiologists who were blinded to the clinical information and pulmonary function test results classified the patients according to the computed tomography features, evidence of fibrotic-like changes, and semi-quantitative quantification of the extent of pulmonary abnormalities. The clinical characteristics and computed tomography findings of patients with normal pulmonary function test results were compared with those of patients with abnormal results. Results: A total of 101 COVID-19 survivors, comprising 48 ambulatory and 53 hospitalized patients, were included at a median of 95 days from initial symptom onset. Computed tomography revealed fibrotic-like changes in 10.9% of patients. A reduction in the diffusion capacity of carbon monoxide was the most common lung function abnormality (19.8%). Abnormal diffusion capacity of carbon monoxide was associated with the presence and extension of lung opacities on chest computed tomography scans and fibrotic pulmonary abnormalities. The sensitivity, specificity, and accuracy of reduced diffusion capacity of carbon monoxide for detecting fibrotic-like pulmonary changes on chest computed tomography scans were 72.7%, 87.8%, and 86.1%, respectively. Conclusion: Our study suggests that the presence of an abnormal diffusion capacity of carbon monoxide in the post-recovery phase of COVID-19 is associated with a greater risk of long-term parenchymal lung disease, as evidenced by the presence of fibrotic-like changes on chest computed tomography scans, such as traction bronchiectasis and architectural distortion. |
|---|---|
| MeSH term(s) | Humans ; Retrospective Studies ; Carbon Monoxide ; COVID-19/diagnostic imaging ; Lung/diagnostic imaging ; Tomography, X-Ray Computed/methods ; Respiratory Function Tests |
| Chemical Substances | Carbon Monoxide (7U1EE4V452) |
| Language | English |
| Publishing date | 2023-12-22 |
| Publishing country | Brazil |
| Document type | Journal Article |
| ZDB-ID | 2418293-X |
| ISSN | 2317-6385 ; 2317-6385 |
| ISSN (online) | 2317-6385 |
| ISSN | 2317-6385 |
| DOI | 10.31744/einstein_journal/2023AO0288 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.